Cargando…
BRCA testing delay during the COVID-19 pandemic: How to act?
Recently, our lab, part of a referral center in Italy, reported its experience regarding the execution of germline BRCA1/2 (gBRCA) testing during the first months of the coronavirus disease-2019 (COVID-19) pandemic, which highlights a substantial reduction (about 60%) compared with the first 2 month...
Autores principales: | Minucci, Angelo, Scambia, Giovanni, De Bonis, Maria, De Paolis, Elisa, Santonocito, Concetta, Fagotti, Anna, Capoluongo, Ettore, Concolino, Paola, Urbani, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733534/ https://www.ncbi.nlm.nih.gov/pubmed/33313973 http://dx.doi.org/10.1007/s11033-020-06060-8 |
Ejemplares similares
-
BRCA testing in a genomic diagnostics referral center during the COVID-19 pandemic
por: Minucci, Angelo, et al.
Publicado: (2020) -
Tumor BRCA testing in ovarian cancer and EQA scheme: our experience of a critical evaluation
por: De Paolis, Elisa, et al.
Publicado: (2021) -
A Whole Germline BRCA2 Gene Deletion: How to Learn from CNV In Silico Analysis
por: Scaglione, Giovanni Luca, et al.
Publicado: (2018) -
A commentary on the discrepancy between blood and tumour
BRCA
testing: An open question
por: De Paolis, Elisa, et al.
Publicado: (2022) -
Preliminary molecular evidence associating a novel BRCA1 synonymous variant with hereditary ovarian cancer syndrome
por: Minucci, Angelo, et al.
Publicado: (2018)